VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,447 | -48.1% | 15,391 | +33.3% | 0.00% | – |
| Q2 2023 | $291,843 | +7.5% | 11,549 | +13.4% | 0.00% | – |
| Q4 2022 | $271,377 | -11.9% | 10,183 | -0.9% | 0.00% | – |
| Q3 2022 | $308,000 | +41.9% | 10,273 | +26.2% | 0.00% | – |
| Q2 2022 | $217,000 | -97.6% | 8,141 | -96.0% | 0.00% | -100.0% |
| Q3 2021 | $8,934,000 | +12138.4% | 205,896 | +12516.2% | 0.00% | – |
| Q1 2021 | $73,000 | -71.3% | 1,632 | -81.9% | 0.00% | – |
| Q4 2020 | $254,000 | +109.9% | 9,014 | +209.4% | 0.00% | – |
| Q3 2020 | $121,000 | -34.2% | 2,913 | -25.0% | 0.00% | – |
| Q2 2020 | $184,000 | +1433.3% | 3,886 | +886.3% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 394 | -56.5% | 0.00% | – |
| Q4 2019 | $11,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |